United States · FDA National Drug Code directory

Naproxen and esomeprazole magnesium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-4166_65b892f2-8385-4bb0-8121-a58b01e8d13d
Product NDC
68788-4166
Form
TABLET, DELAYED RELEASE
Composition / generic term
Naproxen and esomeprazole magnesium
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20260723
Source listing expiry
20271231

Source-listed ingredients

  • NAPROXEN — 375 mg/1
  • ESOMEPRAZOLE MAGNESIUM TRIHYDRATE — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4166-3) · 68788-4166-3
  • 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4166-6) · 68788-4166-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →